Variant-Matched Vaccines

Cross-source consensus on Variant-Matched Vaccines from 1 sources and 4 claims.

1 sources · 4 claims

Uses

Task II evaluates a variant-matched investigational vaccine against a new single circulating strain using immune measurements against that strain. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
Task II uses an immunobridging marker measured against the currently circulating variant. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
Placebo risk in the new variant setting is not identifiable from immunobridging data alone. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
The Task II model scales controlled risk by a relative transmissibility factor. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data